Congratulations to the following companies selected to participate in Innovation AveNEW at SLAS Europe 2023!
Adaptyv Bio (Switzerland)
Bionomous SA (Switzerland)
ELEMENTA LABS B.V. (Netherlands)
faCellitate GmbH (Germany)
FOx BIOSYSTEMS (Belgium)
goodBot UG (Germany)
Macula Vision Systems (USA)
mo:re GmbH (Germany)
Nagi Bioscience (Switzerland)
Brain in a Dish: Neurix SA, 2021 Innovation AveNEW participant
At the Touch of Your Screen: FLUICS GmbH, 2021 Innovation AveNEW participant
Espresso Machine for DNA: Kilobaser GmbH, 2021 Innovation AveNEW participant
Like Recipes in a Kitchen: LabVoice, 2021 Innovation AveNEW participant
The Importance of Science and Health: Newormics, 2021 Innovation AveNEW participant
Mid-Brain Organoids: OrganoTherapeutics, 2021 Innovation AveNEW participant and New Product Award winner
2019 Ignite Award Winner: SEED Biosciences
Interested companies must align in some fashion with the area of life sciences and technology and while not required, an established relationship with a university, bioscience incubator or research institution is preferable. The company’s products and/or services must be available for sale/distribution within the year of their conference participation.
All applications are reviewed by the Innovation AveNEW Review Panel, who will evaluate applications for technical merit and commercial feasibility as well as other criteria, inclusive of, but not limited to:
SLAS reserves the right to select and deselect any company at any given time. All decisions are final. Companies selected for participation in Innovation AveNEW must agree to and adhere to the rules and regulations for participation.
SLAS is dedicated to advancing life sciences discovery and technology and connecting its users to each other. To fulfill that mission, companies selected to participate in Innovation AveNEW receive at no cost:
Deadline for Innovation AveNEW Applicants — Monday, 13 March
Need more information? Contact Stephanie Salerno, Program Coordinator